Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 12 studies | 68% ± 16% | |
| GABAergic neuron | 10 studies | 59% ± 21% | |
| interneuron | 6 studies | 70% ± 11% | |
| neuron | 5 studies | 42% ± 23% | |
| astrocyte | 4 studies | 37% ± 23% | |
| granule cell | 4 studies | 50% ± 14% | |
| oligodendrocyte precursor cell | 4 studies | 28% ± 7% | |
| retina horizontal cell | 4 studies | 67% ± 18% | |
| retinal ganglion cell | 4 studies | 40% ± 27% | |
| GABAergic interneuron | 3 studies | 63% ± 1% | |
| microglial cell | 3 studies | 39% ± 19% | |
| amacrine cell | 3 studies | 47% ± 11% | |
| glycinergic amacrine cell | 3 studies | 46% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 12 studies | 49% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 78% | 34.12 | 2048 / 2642 | 36% | 1.15 | 256 / 705 |
| spleen | 95% | 63.75 | 228 / 241 | 0% | 0 | 0 / 0 |
| lung | 73% | 15.35 | 421 / 578 | 2% | 0.09 | 25 / 1155 |
| peripheral blood | 71% | 179.08 | 663 / 929 | 0% | 0 | 0 / 0 |
| liver | 63% | 12.28 | 142 / 226 | 1% | 0.11 | 6 / 406 |
| stomach | 55% | 14.51 | 198 / 359 | 2% | 0.12 | 6 / 286 |
| blood vessel | 53% | 15.25 | 710 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 37% | 5.52 | 449 / 1204 | 0% | 0 | 0 / 0 |
| heart | 36% | 7.57 | 306 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 16% | 2.07 | 40 / 258 | 13% | 0.27 | 29 / 230 |
| kidney | 25% | 3.02 | 22 / 89 | 2% | 0.05 | 19 / 901 |
| breast | 17% | 1.57 | 76 / 459 | 1% | 0.04 | 9 / 1118 |
| pancreas | 14% | 1.55 | 47 / 328 | 3% | 0.08 | 5 / 178 |
| intestine | 16% | 1.68 | 155 / 966 | 1% | 0.02 | 4 / 527 |
| uterus | 12% | 1.32 | 20 / 170 | 1% | 0.01 | 3 / 459 |
| esophagus | 9% | 0.97 | 136 / 1445 | 2% | 0.09 | 4 / 183 |
| bladder | 10% | 0.90 | 2 / 21 | 2% | 0.03 | 8 / 504 |
| thymus | 9% | 0.85 | 59 / 653 | 0% | 0.00 | 1 / 605 |
| ovary | 7% | 0.73 | 12 / 180 | 1% | 0.01 | 3 / 430 |
| prostate | 7% | 0.64 | 16 / 245 | 0% | 0.00 | 1 / 502 |
| skin | 4% | 0.41 | 76 / 1809 | 0% | 0.00 | 1 / 472 |
| muscle | 2% | 0.24 | 17 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042391 | Biological process | regulation of membrane potential |
| GO_0007623 | Biological process | circadian rhythm |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0034702 | Cellular component | monoatomic ion channel complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0005242 | Molecular function | inward rectifier potassium channel activity |
| Gene name | KCNH7 |
| Protein name | Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Voltage-gated potassium channel subunit Kv11.3) |
| Synonyms | ERG3 |
| Description | FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium channel. Channel properties may be modulated by cAMP and subunit assembly. |
| Accessions | ENST00000328032.8 [Q9NS40-2] ENST00000332142.10 [Q9NS40-1] Q9NS40 |